OXON is delighted to be supporting ICPE again this year, albeit virtually.
We have a virtual exhibition booth from which we will be happy to speak with you about our specialisation in data collection, secondary data and hybrid real world studies, pragmatic trials and meta-analyses to help plan, design and implement RWE for safety, market access and drug development.
Join and chat with our experts live about our hybrid pregnancy studies, PASS & PAES, Risk Minimisation, our EDC and more:
- Oral presentations on PASS studies in which discuss hybrid designs and with which we have a record of successful EMA-approved studies and our database of PASS studies with data obtained through freedom of information from EMA.
- An academic programme of research in COVID-19 studies, from which we can run ´spin-off´ data collection studies in hospitals for planning trials and evidence value dossiers for companies – one top-10 pharma company has taken advantage of this experience already. We are working closely with a network of hospitals in Europe.